Liver Resection Remains a Safe Procedure After Neoadjuvant Chemotherapy Including Bevacizumab: A Case-Controlled Study

This study was conducted to analyze if the combination of Bevacizumab with standard chemotherapy increases postoperative morbidity and mortality after resection of colorectal liver metastases as compared with resection after chemotherapy alone. Parameters contributing to an increased morbidity were...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of surgery 2010-07, Vol.252 (1), p.124-130
Hauptverfasser:	TAMANDL, Dietmar, GRUENBERGER, Birgit, KLINGER, Markus, HERBERGER, Beata, KACZIREK, Klaus, FLEISCHMANN, Edith, GRUENBERGER, Thomas
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Antineoplastic Agents - therapeutic use Bevacizumab Biological and medical sciences Case-Control Studies Colorectal Neoplasms - pathology Female General aspects Hepatectomy Humans Liver Neoplasms - drug therapy Liver Neoplasms - secondary Liver Neoplasms - therapy Liver, biliary tract, pancreas, portal circulation, spleen Male Medical sciences Middle Aged Neoadjuvant Therapy Postoperative Complications Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the digestive system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!